Amarin Corp Ads (AMRN) 2.10 $AMRN Featured Research

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 6:07 AM

Amarin Corp Ads (AMRN) 2.10 $AMRN

Featured Research Report on Drug Manufacturers Stocks
ACCESSWIRE - Tue Jun 14, 8:15AM CDT
LONDON, UK / ACCESSWIRE / June 14, 2016 / ActiveWallSt.com announces the list of stocks for today's research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Drug Manufacturers-Other industry. Companies recently under review include Ionis Pharma, Depomed, Amarin, and United Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:
UTHR: 105.28 (+1.92), AMRN: 2.10 (+0.04), DEPO: 19.67 (+0.55), IONS: 23.60 (+1.01)

Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Patients With Type 2 Diabetes and Persistent High Triglycerides
Marketwired - Sat Jun 11, 10:00AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 11, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced additional data on Vascepa (icosapent ethyl) presented at the annual meeting of the American Diabetes Association (ADA) supporting its efficacy in reducing concentrations of potentially atherogenic lipoproteins (lipoproteins that could promote fat deposits in arteries) in patients with Type 2 diabetes and persistent high triglyceride (TG) levels despite statin therapy.
AMRN: 2.10 (+0.04)

Vascepa(R) (Icosapent Ethyl) Data to Be Presented at American Diabetes Association's 76th Scientific Sessions
Marketwire Canada - Mon Jun 06, 6:30AM CDT
BEDMINSTER, NJ AND DUBLIN, IRELAND--(Marketwired - June 06, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced that new data related to Vascepa® (icosapent ethyl) will be presented at the upcoming American Diabetes Association (ADA) 76th Scientific Sessions in New Orleans (June 10-14) and published as an abstract in the Diabetes® Abstract Book.
AMRN: 2.10 (+0.04)

Amarin (AMRN) Looks Good: Stock Adds 6.7% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 7:40AM CDT
Amarin Corporation plc (AMRN) saw its shares rise almost 7% in the last trading session.
ANIP: 56.27 (+3.48), AMRN: 2.10 (+0.04)

Amarin to Present at the Jefferies 2016 Global Healthcare Conference
Marketwire Canada - Wed Jun 01, 7:01AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 01, 2016) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at the Jefferies 2016 Global Healthcare Conference in New York City on Tuesday, June 7, 2016, at 8:00 a.m. ET.
AMRN: 2.10 (+0.04)

Amarin Announces FDA New Chemical Entity Market Exclusivity Determination for Vascepa(R) (icosapent ethyl) Capsules
Marketwire Canada - Tue May 31, 12:30PM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 31, 2016) - Amarin Corporation plc (NASDAQ: AMRN) announced today that the U.S. Food and Drug Administration (FDA) has determined that Vascepa® (icosapent ethyl) capsules are eligible for five-year, new chemical entity (NCE), marketing exclusivity pursuant to the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act. This determination provides Vascepa with the benefits of NCE exclusivity afforded by statute. NCE exclusivity for Vascepa runs from its date of FDA approval on July 26, 2012 and extends until July 26, 2017. The statutory 30-month stay triggered by patent litigation following generic application submissions permitted on July 26, 2016 would expire on January 26, 2020, seven-and-a-half years from FDA approval.
AMRN: 2.10 (+0.04)

Vascepa(R) (Icosapent Ethyl) Showed Significant Reductions in Key Lipid Parameters in Subgroup of Women With Very High Triglyceride Levels
Marketwired - Fri May 20, 9:50AM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - May 20, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced the presentation of a poster at the annual meeting of the National Lipid Association (NLA) further characterizing the efficacy and safety of Vascepa® (icosapent ethyl) in women with very high triglyceride levels.
AMRN: 2.10 (+0.04)

Vascepa(R) (icosapent ethyl) and Eicosapentaenoic Acid (EPA) Data to Be Presented at National Lipid Association 2016 Scientific Sessions
Marketwire Canada - Wed May 11, 6:30AM CDT
BEDMINSTER, NJ AND DUBLIN, IRELAND--(Marketwired - May 11, 2016) - Amarin Corporation plc (NASDAQ: AMRN) today announced that new data related to Vascepa® (icosapent ethyl) and eicosapentaenoic acid (EPA) will be presented at the upcoming National Lipid Association 2016 Scientific Sessions in New Orleans (May 19-22).
AMRN: 2.10 (+0.04)

Amarin Reports First Quarter 2016 Financial Results and Provides Update on Operations
Marketwire Canada - Thu May 05, 6:00AM CDT
Product Revenue up 63% Over Prior Year; REDUCE-IT Cardiovascular Outcomes Study Achieves Target Enrollment; Preparation for Interim Analysis by Independent Data Monitoring Committee Underway; Management to Host Conference Call at 8:00 a.m. ET Today
AMRN: 2.10 (+0.04)

Investor Calendar Invites You to the Amarin First Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, May 5, 2016
ACCESSWIRE - Wed May 04, 3:05PM CDT
BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / May 4, 2016 / Amarin Corporation plc (NASDAQ: AMRN) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Thursday, May 5, 2016 at 8:00 AM Eastern Time.
AMRN: 2.10 (+0.04)

Amarin to Report First Quarter 2016 Results and Host Conference Call on May 5, 2016
Marketwired - Thu Apr 28, 6:44AM CDT
Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's first quarter 2016 financial results and provide an operational update on Thursday, May 5, at 8:00 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day.
AMRN: 2.10 (+0.04)

3 Biotech Stocks With Scary-High Debt-to-Capital Ratios
Todd Campbell, The Motley Fool - Motley Fool - Mon Apr 11, 7:40AM CDT
SOURCE: FLICKR USER GOTCREDIT.COM. Biotech companies pour millions of dollars into research programs that may or may not pan out, and money to fund that research can come from issuing stock or taking on debt. Debt isn't always a bad thing, but too...
SGYP: 3.80 (unch), MACK: 6.12 (-0.08), IRWD: 12.95 (+0.31), AMRN: 2.10 (+0.04)

Penny Stocks To Watch: Thursday's List of Trending Small Cap Stocks April 7th
ACCESSWIRE - Thu Apr 07, 1:13PM CDT
MIAMI, FL / ACCESSWIRE / April 7, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. AMRN, CBAY, RXMD, and NWBO have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the OTC, NASDAQ and NYSE subscribe to our newsletter at DailyStockReporter.com.
AMRN: 2.10 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honeywell Aerospace Faces Securities Lawsuit Amid Turmoil

Legal Storms Brewing for Honeywell Aerospace Well, stock aces, here's a curveball for anyone with a stake in Honeywell Aerospace Inc. (NASDAQ: HONA). The DJS Law Group tossed a legal grenade right into the heart of Honeywell's operations. Allegations fly that the company's been playing fast and loose with the truth during its supply chain saga. The Heart of the Allegation...

Laredo Oil Eyes Big Gains in Argentina's Oil Play

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

Selling Montana Cabins: Tips from Shawna Norry

Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...

Dairy Blends Market Eyes USD 15.38B by 2035 Growth

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

PAG Secures $355M to Accelerate Aggressive Growth

Platform Accounting's Bold Expansion Move When you hear about a $355 million strategic financing round, it paints a picture of company ambitions colored in big, bold strokes. Platform Accounting Group (PAG) has managed to secure such a hefty financial backing from Treville Capital Group, taking a serious shot at expanding its footprint and offerings. This is no small...

Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Tutoring America Champions Educational Equity with Grants

Bolstering Educational Support for Low-Income Students In a world where opportunities hang on the thread of education, Tutoring America stands as a beacon for those left behind. This nonprofit tackles the education gap head-on, aiming to uplift low-income kids before they hit high school turbulence. Frankly, what they're doing is more than just good work—it's laying the...

Primoris Faces Allegations Over Misleading Project Costs

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Mastering Power Efficiency with Phase Converters

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...